Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer
MetadataShow full item record
CitationMeng, Shasha, Immaculata De Vivo, Liming Liang, Zhibin Hu, David C. Christiani, Edward Giovannucci, and Jiali Han. 2016. “Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer.” Oncotarget 7 (19): 27307-27312. doi:10.18632/oncotarget.8426. http://dx.doi.org/10.18632/oncotarget.8426.
AbstractWe prospectively investigated the relationship between mtCN and the risk of lung cancer in 463 case-control pairs from two prospective cohort studies, the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). The adjusted least-squares means of log-transformed mtCN (log_mtCN) by smoking status were estimated by generalized linear models. Multivariable conditional logistic regression model adjusting for confounders was used to obtain the odds ratios (ORs) and 95% confidence intervals (CIs) for the association between log_mtCN and lung cancer risk. The adjusted least-squares mean of log_mtCN in heavy smokers was significantly lower than that in never smokers (P = 0.05). Compared to the high log_mtCN group, the risk of lung cancer was 1.29 (95% CI = 0.89–1.87) for the median group, and 1.11 (95% CI = 0.75–1.64) for the low group. Among current smokers, compared to participants with high levels of log_mtCN, those with median levels had a significantly higher risk of lung cancer (OR = 2.09; 95% CI = 1.12–3.90), but not those with low levels (OR = 1.37; 95% CI = 0.75–2.48). Further studies are warranted to confirm these findings.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:29408432